upfront therapy for lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia

Steven P. Treon, MD, PhD, of the Dana-Farber Cancer Institute, discusses the question of what is the best upfront therapy for lymphoplasmacytic lymphoma/Waldenström’s macroglobulinemia at the 2016 Pan Pacific Lymphoma Conference.

Click Here to view the presentation